BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LBL-047 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LBL-047\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07323173-5562@assetmemo.bio
DTSTAMP:20261121T004049Z
DTSTART;VALUE=DATE:20271216
DTEND;VALUE=DATE:20271217
SUMMARY:LBL-047: Phase 1 readout est. (NCT07323173)
DESCRIPTION:LBL-047\, phase 1\, Systemic Lupus Erythematosus.\nStudy: A Stu
 dy to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patient
 s With Systemic Lupus Erythematosus\nEstimated primary completion: 16 Dece
 mber 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/lbl-047#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT073231
 73
URL:https://assetmemo.bio/drug/lbl-047#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
